The Importance of Avoiding Conclusions for the Right Diagnostic in the Wrong Population.
Critical care medicine(2017)
Immunexpress
Abstract
Immunexpress, Seattle, WA Supported, in part, by Immunexpress. Dr. McHugh is an employee and shareholder of Immunexpress, which holds the intellectual property relating to SeptiCyte technology. He received funding from Immunexpress (full-type employee and shareholder).
MoreTranslated text
PDF
View via Publisher
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper
Summary is being generated by the instructions you defined